Deutsche Bank
KPTI icon

Deutsche Bank’s Karyopharm Therapeutics KPTI Stock Holding History

Deutsche Bank’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-84,585
Closed -$863K – 3619
2024
Q4 		$863K Hold
84,585
– – ﹤0.01% 2324
2024
Q3 		$1.05M Hold
84,585
– – ﹤0.01% 2086
2024
Q2 		$1.1M Sell
84,585
-3,747
-4% -$62K ﹤0.01% 1942
2024
Q1 		$2M Sell
88,332
-135
-0.2% -$2.37K ﹤0.01% 1657
2023
Q4 		$1.15M Buy
88,467
+84,585
+2,179% +$1.14M ﹤0.01% 1944
2023
Q3 		$78K Sell
3,882
-102,330
-96% -$2.3M ﹤0.01% 3270
2023
Q2 		$2.85M Sell
106,212
-3,450
-3% -$149K ﹤0.01% 1457
2023
Q1 		$6.4M Buy
109,662
+70,040
+177% +$3.46M ﹤0.01% 1128
2022
Q4 		$2.02M Buy
39,622
+34
+0.1% +$2.36K ﹤0.01% 1646
2022
Q3 		$3.24M Sell
39,588
-45
-0.1% -$3.36K ﹤0.01% 1393
2022
Q2 		$2.68M Sell
39,633
-329
-0.8% -$30.2K ﹤0.01% 1600
2022
Q1 		$4.42M Buy
39,962
+36,764
+1,150% +$4.58M ﹤0.01% 1472
2021
Q4 		$308K Sell
3,198
-11,778
-79% -$1.17M ﹤0.01% 3130
2021
Q3 		$1.31M Sell
14,976
-140
-0.9% -$14.5K ﹤0.01% 2441
2021
Q2 		$2.34M Sell
15,116
-4,121
-21% -$598K ﹤0.01% 2085
2021
Q1 		$3.04M Buy
19,237
+7,910
+70% +$1.67M ﹤0.01% 1873
2020
Q4 		$2.63M Buy
11,327
+2,890
+34% +$670K ﹤0.01% 1746
2020
Q3 		$1.85M Sell
8,437
-6,963
-45% -$1.7M ﹤0.01% 1797
2020
Q2 		$4.38M Buy
15,400
+5,345
+53% +$1.58M ﹤0.01% 1373
2020
Q1 		$2.9M Buy
10,055
+3,240
+48% +$894K ﹤0.01% 1513
2019
Q4 		$1.96M Buy
6,815
+5,697
+510% +$1.24M ﹤0.01% 1979
2019
Q3 		$161K Sell
1,118
-4,591
-80% -$622K ﹤0.01% 3314
2019
Q2 		$511K Sell
5,709
-54,888
-91% -$4.41M ﹤0.01% 3267
2019
Q1 		$5.31M Buy
60,597
+28,642
+90% +$3.17M ﹤0.01% 1836
2018
Q4 		$4.49M Buy
31,955
+8,850
+38% +$1.49M ﹤0.01% 1846
2018
Q3 		$5.9M Buy
23,105
+1,075
+5% +$297K ﹤0.01% 2052
2018
Q2 		$5.62M Buy
22,030
+9,398
+74% +$2.32M ﹤0.01% 2215
2018
Q1 		$2.54M Buy
12,632
+74
+0.6% +$14.8K ﹤0.01% 2705
2017
Q4 		$1.81M Buy
12,558
+1,740
+16% +$279K ﹤0.01% 2790
2017
Q3 		$1.78M Sell
10,818
-547
-5% -$78.3K ﹤0.01% 2616
2017
Q2 		$1.54M Buy
11,365
+2,447
+27% +$362K ﹤0.01% 2724
2017
Q1 		$1.72M Buy
8,918
+1,020
+13% +$164K ﹤0.01% 2346
2016
Q4 		$1.11M Buy
7,898
+1,371
+21% +$185K ﹤0.01% 2623
2016
Q3 		$951K Buy
6,527
+887
+16% +$107K ﹤0.01% 2853
2016
Q2 		$567K Sell
5,640
-1,190
-17% -$155K ﹤0.01% 3212
2016
Q1 		$913K Sell
6,830
-100
-1% -$11K ﹤0.01% 2870
2015
Q4 		$1.38M Buy
6,930
+1,138
+20% +$246K ﹤0.01% 2678
2015
Q3 		$914K Buy
5,792
+349
+6% +$93.3K ﹤0.01% 3010
2015
Q2 		$2.22M Sell
5,443
-1,796
-25% -$776K ﹤0.01% 2372
2015
Q1 		$3.32M Buy
7,239
+70
+1% +$30.2K ﹤0.01% 2076
2014
Q4 		$4.02M Buy
7,169
+1,833
+34% +$1.04M ﹤0.01% 2132
2014
Q3 		$2.79M Buy
5,336
+5,060
+1,833% +$2.86M ﹤0.01% 2267
2014
Q2 		$192K Buy
276
+117
+74% +$54.5K ﹤0.01% 4153
2014
Q1 		$73K Sell
159
-2,043
-93% -$1.04M ﹤0.01% 4372
2013
Q4 		$756K Buy
+2,202
New +$608K ﹤0.01% 2820

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Deutsche Bank's KPTI Position: Q1 2025 in Review

Deutsche Bank sold out of Karyopharm Therapeutics (KPTI) in Q1 2025, closing a stake of 84,585 shares — an estimated $863K sold.

Deutsche Bank first reported a position in KPTI in Q4 2013 and held it in 45 quarters. The position peaked at $6.4M in Q1 2023. 49 funds tracked by Wall St. Rank hold KPTI as of Q1 2025.

  • Deutsche Bank reported no remaining Karyopharm Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Deutsche Bank sold 84,585 Karyopharm Therapeutics shares in Q1 2025, an estimated $863K.
  • Deutsche Bank first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 45 quarters.
  • Deutsche Bank's Karyopharm Therapeutics position peaked at $6.4M in Q1 2023.
  • 49 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2025.

Based on Deutsche Bank's 13F filing for Q1 2025, filed 9 May 2025.